Researchers explore how memory-making genes could be a target for Alzheimer’s treatments. Scientists from MIT examine strategies to block an enzyme from impeding that…
Wondering how to prevent Alzheimer’s? Delaying the onset of Alzheimer’s disease by just five years would cut the number of clinically affected people by…
OAKLAND, Calif. — The question came as a shock to Dorothy Reeves: Would she be willing to donate her husband’s brain for research? She…
We know that your genes play a big part in your risk for various diseases, but up until the ’90s it was believed that…
Scientists in the UK are growing mini brains – yes, brains – with the intention of one day using them to fight Alzheimer’s disease….
Expert Opinion: Who Should Get A Genetic Test for Alzheimer’s Disease? Direct-to-consumer genetic testing is becoming more common as people opt to understand how…
For decades, humans were thought to be the only species to develop Alzheimer’s disease. But in a study published this week in the journal…
We know that access to adequate care can be a challenge for Alzheimer’s and dementia patients. That’s especially true in a hospital setting, according…
Inflammation is a major suspect in the search for a cure for Alzheimer’s disease. Often patients only see symptoms of the disease when they…
We know that Alzheimer’s disease is defined by the presence of beta amyloid plaques and tau tangles in the brain but scientists are still…
Scientists are pushing the boundaries of their search to find a cure (or cause) of Alzheimer’s disease to include identifying the key risk factors…
Is it possible to delay the progression of cognitive decline through lifestyle interventions? It’s a question many people want to know and could shed…
Getting a diagnosis for Alzheimer’s can be a huge challenge – the only scans that confirm the presence of the disease (PET or spinal…
We’ve heard from many patients and caregivers about how difficult it is to get a diagnosis for Alzheimer’s disease but we haven’t heard the…
Here’s a quick look at a 2017 analysis of the Alzheimer’s drug pipeline. Twenty-seven Alzheimer’s drugs in Phase III clinical trials and eight drugs…